Is Ajanta Pharma Ltd halal to invest in?

As of July 2026, Ajanta Pharma Ltd AJANTPHARM.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Ajanta Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ajanta Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Ajanta Pharma Ltd?

Muslim investors may consider investing in Ajanta Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ajanta Pharma Ltd classified as HALAL?

Musaffa determines the Shariah status of Ajanta Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ajanta Pharma Ltd updated?

The Shariah compliance status of Ajanta Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ajanta Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ajanta Pharma Ltd?

You can check the latest Shariah compliance status of Ajanta Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Ajanta Pharma Ltd AJANTPHARM.NS

Last Updated: Jul 22, 12:00 AM·NSE

AJANTPHARM.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Ajanta Pharma Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Ajanta Pharma Ltd. Stock Analysis AJANTPHARM.NS

India Health Care Mid Cap Report: 2026 Annual

Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The company is focused on branded generic businesses across India, Asia, and Africa. The company has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

Key Statistics of Ajanta Pharma Ltd (AJANTPHARM.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹3,432.50₹3,574.00

Today's Open

₹3,574.00

Volume

97.05K

P/E Ratio (TTM)

42.33

52 Week Range

₹2,329.90₹3,598.80

Market Cap

414.47B

Avg. Volume

102.77K

Dividend Yield

0.78%

Financial Metrics & Statements of Ajanta Pharma Ltd (AJANTPHARM.NS)

Super Investors Invested in Ajanta Pharma Ltd (AJANTPHARM.NS)

FAQ's for Ajanta Pharma Ltd (AJANTPHARM.NS)

As of July 2026, Ajanta Pharma Ltd AJANTPHARM.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ajanta Pharma Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Ajanta Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Ajanta Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Ajanta Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Ajanta Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.